The technology, called LithoVue Elite, is a ureteroscope with an in-built pressure sensor, providing real-time readings.

Boston Scientific (NYSE:BSX) is scheduled to report its earnings on Wednesday, July 23, 2025. Over the past five years, BSX stock has demonstrated a positive one-day return in 60% of instances ...

Boston Scientific Corporation (NYSE:BSX) Q2 2025 Earnings Conference Call July 23, 2025 8:00 AM ETCompany ParticipantsJonathan R.

Boston Scientific raised its annual profit forecast on Wednesday, banking on strong demand for its heart devices, and trimmed its expectation for tariff-related costs to half of the previously ...

Boston Scientific (BSX) delivered earnings and revenue surprises of +4.17% and +3.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Boston will begin fining Republic Services over lack of trash pickup amid worker strike, Wu says By Niki Griswold Globe Staff,Updated July 23, 2025, 11:20 a.m.

Boston Scientific bumped up its financial forecasts for the remainder of this year after reporting double-digit growth across multiple medtech segments. | The company logged a 22.8% increase in ...

About Boston Scientific Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world.

Boston Scientific beats Q2 estimates, posts 22.8% revenue growth, and raises full-year outlook on strong cardiovascular and MedSurg performance.

For the current quarter ending in September, Boston Scientific expects its per-share earnings to range from 70 cents to 72 cents. The company expects full-year earnings in the range of $2.95 to $2 ...